Tamara Berthoud

Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1

Tamara Berthoud, Matthew M. Hamill, Patrick Lillie et al. · Clinical Infectious Diseases · 2010 · 382 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans

Patrick Lillie, Tamara Berthoud, Timothy J. Powell et al. · Clinical Infectious Diseases · 2012 · 249 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

Daniel P. Webster, Susanna Dunachie, Jenni M. Vuola et al. · Proceedings of the National Academy of Sciences · 2005 · 244 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens

Richard Antrobus, Lynda Coughlan, Tamara Berthoud et al. · Molecular Therapy · 2013 · 198 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8 ⁺ T-Cell Responses

Arturo Reyes‐Sandoval, Tamara Berthoud, Nicola Alder et al. · Infection and Immunity · 2009 · 178 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17